Katharina Schumann

1PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|May 07, 2025
Switching PD-1 to BRAF + MEK inhibition improves recurrence-free survival in patients receiving a second course of adjuvant melanoma therapy.

Katharina Schumann, Kai Christian Klespe, Cornelia Mauch

Pageof 1

Frequent Collaborators

1 joint publications

Alexander Thiem

1 joint publications

Wiebke K Peitsch

1 joint publications

Andreas Dominik Braun

1 joint publications

Miriam Mengoni